Comparison of Tobramycin, Gentamicin, Colistin, and Carbenicillin in Pseudomonas Sepsis in Monkeys

AUTOR(ES)

Saslaw, Samuel

RESUMO

Intravenous inoculation of 3.4 × 1010 to 7.4 × 1010Pseudomonas aeruginosa organisms into rhesus monkeys 4 days after intravenous or intratracheal inoculation of 2.0 to 2.5 mg of vincristine sulfate resulted in fatal sepsis in eight of nine monkeys. After intramuscular administration, in two equal doses, of 5 mg of tobramycin, gentamicin, and colistin per kg per day beginning 16 hr after challenge, 4 of 11, 4 of 11, and 3 of 10 monkeys died, respectively. Administration of daily doses of 100 to 400 mg of carbenicillin per kg was followed by death in 5 of 12. Duration of illness in the surviving monkeys in each therapy group was similar. Under the conditions of this study, prior administration of vincristine sulfate resulted in a decrease in leukocytes and enhanced susceptibility to Pseudomonas infection. Using this model for studies of comparative efficacy of antibiotics, we observed comparable results after treatment with tobramycin, gentamicin, colistin, and carbenicillin.

Documentos Relacionados

• Comparison of Colistin-Carbenicillin, Colistin, and Carbenicillin in Pseudomonas Sepsis in Monkeys
• Comparison of Gentamicin, Carbenicillin and Gentamicin, and Carbenicillin in Pseudomonas Sepsis in Monkeys
• Studies on the Susceptibility of 150 Consecutive Clinical Isolates of Pseudomonas aeruginosa to Tobramycin, Gentamicin, Colistin, Carbenicillin, and Five Other Antimicrobials
• Susceptibility of 1,500 Isolates of Pseudomonas aeruginosa to Gentamicin, Carbenicillin, Colistin, and Polymyxin B
• In Vitro Comparison of Gentamicin, Tobramycin, Sisomicin, and Netilmicin